Table 1.
RD CsA (n = 99) | ST CsA (n = 100) | |
---|---|---|
Recipient age (years) | 49.8 ± 11.77 | 49.4 ± 10.44 |
Female recipient | 25 (25.3%) | 22 (22.0%) |
White recipient | 79 (79.8%) | 77 (77.0%) |
End stage disease leading to transplantation | ||
Cardiomyopathy | 49 (49.5%) | 55 (55.0%) |
Coronary artery disease | 32 (32.3%) | 30 (30.0%) |
Other | 18 (18.2%) | 15 (15.0%) |
Ventricular assist device | 12 (12.1%) | 8 (8.0%) |
Panel reactive antibodies (%) | ||
0%–10% | 84 (84.5%) | 87 (87.0%) |
>10% | 1 (1.0%) | 0 |
Missing | 14 (14.1%) | 13 (13.0%) |
Donor age (years) | 35.3±13.9 | 35.5±11.9 |
Female donor | 24 (24.2%) | 35 (35.0%) |
Cytomegalovirus D+/R− | 23 (23.2%) | 17 (17.0%) |
Cold ischaemia time (hours) [mean ± SD] | 2.8 ± 1.1 | 3.2 ± 1.2 |
Diabetes | 31 (31.3%) | 31 (31.0%) |
Hypertension | 45 (45.5%) | 53 (53.0%) |